Complete heart block in dengue complicating management of shock due to both bleeding and leakage: a case report

BMC Research Notes

Aruna Kulatunga¹  Damith Kumara¹  Tharshana Kugadas¹  Isurujith Liyanage¹  Sandamalee Herath¹  Jevon Yudhishdran¹  Mitrakrishnan Rayno Navinan¹ 

[1] National Hospital of Sri Lanka, Colombo, Sri Lanka

关键词: Expanded dengue syndrome;    Electrocardiograms;    Arrhythmia;    Heart block;    Myocarditis;    Dengue;   

Others  :  1135373
DOI  :  10.1186/s13104-015-1036-9

 received in 2014-10-11, accepted in 2015-02-24,  发布年份 2015

【 摘 要 】

Background

The spread of Dengue virus infection is reaching pandemic proportions. Dengue is usually dreaded for causing shock due to capillary leakage. However the clinical spectrum of dengue is vast and the newly incorporated expanded dengue syndrome introduces a wide range of presentations that are rarely observed and appreciated but nevertheless have the potential to cause significant morbidity and even mortality. Cardiac involvement in dengue is one such example.

Case presentation

A 26 year old South-Asian female presented in a state of haemodynamic shock with a history of fever and use of non-steroidal anti inflammatory drugs. Dengue was suspected clinically and later confirmed. Following stabilization and while still in the febrile phase the patient developed bradycardia with dynamic electrocardiogram changes which evolved into complete heart block. However there was no circulatory compromise. Clinical picture was further complicated by the development of dengue haemorhaghic fever and cautious fluid resuscitation was carried out in correlation to clinical and haematological parameters. Impaired coagulation profile necessitated administration of activated factor seven on the backdrop of low platelets and bleeding. Cardiac pacing could be avoided due to maintenance of vitals within acceptable parameters.

Conclusion

Expanded dengue syndrome should be given greater appreciation as not all may be benign. Cardiovascular system involvement in dengue has the potential to cause significant morbidity and mortality. Careful interpretation of clinical parameters will help in the institution of the appropriate management and help avoid unnecessary invasive interventions. Screening of dengue patients with timely electrocardiographs would be useful to detect cardiac involvement. Guidance on managing atypical manifestations of dengue expanded syndrome should available to help clinicians dictate treatment.

【 授权许可】

   
2015 Navinan et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]WHO. Dengue and severe dengue: Fact sheet N°117. WHO media centre; 2014 [updated March 2014]; Available from: http://www.who.int/mediacentre/factsheets/fs117/en/.
• [2]World-Health-Organization: Comprehensive Guideleines For the Prevention and Control of Dengue and Dengue Haemorrhagic Fever: Revised and expanded edition. WHO, India; 2011.
• [3]La-Orkhun V, Supachokchaiwattana P, Lertsapcharoen P, Khongphatthanayothin A: Spectrum of cardiac rhythm abnormalities and heart rate variability during the convalescent stage of dengue virus infection: a Holter study. Ann Trop Paediatr 2011, 31(2):123-8. Epub 2011/05/18
• [4]Lee CH, Teo C, Low AF: Fulminant dengue myocarditis masquerading as acute myocardial infarction. Int J Cardiol 2009, 136(3):e69-71. Epub 2008/08/15
• [5]Pesaro AE, D’Amico E, Aranha LF: Dengue: cardiac manifestations and implications in antithrombotic treatment. Arq Bras Cardiol 2007, 89(2):e12-5. Epub 2007/09/18
• [6]Saldarriaga GC, Roncancio G, González N, Fortich F: Manifestaciones cardiacas del dengue: Reporte de una serie de casos durante la epidemia colombiana de 2010. Revista Colombiana de Cardiología. 2013, 20:366-9.
• [7]Ron-Guerrero CS, Ron-Magaña AL: Dengue fatal: reporte de cuatro casos en Nayarit, México. Medicina Interna de México 2011, 27(4):385-9.
• [8]Nimmagadda SS, Mahabala C, Boloor A, Raghuram PM, Nayak UA: Atypical manifestations of Dengue Fever (DF) - Where do we stand today? J Clin Diagn Res 2014, 8(1):71-3.
• [9]Horta Veloso H, Ferreira Junior JA, de Paiva JMB, Faria Honorio J, Junqueira Bellei NC, de Paola AAV: Acute atrial fibrillation during dengue hemorrhagic fever. Braz J Infect Dis 2003, 7(6):418-22. Epub 2003/11/26
• [10]Matthias AT, Indrakumar J, Gunatilake SB: Ventricular trigeminy in a patient with serologically confirmed dengue haemorrhagic fever. Int Arch Med. 2014, 7:28. Epub 2014/06/07 BioMed Central Full Text
• [11]Kularatne SA, Pathirage MM, Kumarasiri PV, Gunasena S, Mahindawanse SI: Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005. Trans R Soc Trop Med Hyg 2007, 101(8):804-8. Epub 2007/04/13
• [12]Zea D, Foley K, Carey J: Myocarditis in a traveler returning from the dominican republic: an unusual presentation of dengue Fever. Am J Trop Med Hyg 2014, 91(1):156-8. Epub 2014/06/04
• [13]Jindal A, Shivpuri D: Heart involvement in dengue viral infection in children. Crit Care Med 2013, 41(12):0090-3493.
• [14]Lim SMS, Hoo FK, Sulaiman WAW: A case of dengue hemorrhagic fever with myocarditis and complete heart block. RMJ 2014, 39(1):104-6.
• [15]Kaushik JS, Gupta P, Rajpal S, Bhatt S: Spontaneous resolution of sinoatrial exit block and atrioventricular dissociation in a child with dengue fever. Singapore Med J 2010, 51(9):e146-8. Epub 2010/10/13
• [16]Martha JW: Total atrioventricular block due to Dengue myocarditis. J Cardiovasc Electrophysiol 2009, 20(S59):1045-3873.
• [17]Promphan W, Sopontammarak S, Pruekprasert P, Kajornwattanakul W, Kongpattanayothin A: Dengue myocarditis. Southeast Asian J Trop Med Public Health 2004, 35(3):611-3. Epub 2005/02/04
• [18]Carter R 3rd, Hinojosa-Laborde C, Convertino VA: Heart rate variability in patients being treated for dengue viral infection: new insights from mathematical correction of heart rate. Front Physiol. 2014, 5:46. Epub 2014/03/13
• [19]Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, Vega MR, et al.: Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J 2010, 29(3):238-42. Epub 2009/12/25
• [20]Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG: Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012, 76(1):16-32.
• [21]Sharma JK, Zaheer S: Variable atrio-ventricular block in dengue fever. J Indian Acad Clin Med 2014, 15(3–4):252-4.
• [22]PPS. Department of Health Revised Dengue Clinical Case Management Guidelines 2011. 2011; Available from: http://www.doh.gov.ph/sites/default/files/revised_%20dengue_clinical_management_guidelines.pdf.
• [23]RuDusky BM: ECG abnormalities associated with hypocalcemia. Chest 2001, 119(2):668-9. Epub 2001/02/15
• [24]Nijjer S, Ghosh AK, Dubrey SW. Hypocalcaemia, long QT interval and atrial arrhythmias. BMJ case reports. 2010;2010:bcr0820092216. Epub 2010/01/01.
• [25]Singhi S, Kissoon N, Bansal A: Dengue e dengue hemorrágico: aspectos do manejo na unidade de terapia intensiva. J Pediatr (Rio J). 2007, 83:S22-35.
• [26]Mekmullica J, Suwanphatra A, Thienpaitoon H, Chansongsakul T, Cherdkiatkul T, Pancharoen C, et al.: Serum and urine sodium levels in dengue patients. Southeast Asian J Trop Med Public Health 2005, 36(1):197-9. Epub 2005/05/24
• [27]Mouallem M, Friedman E, Shemesh Y, Mayan H, Pauzner R, Farfel Z: Cardiac conduction defects associated with hyponatremia. Clin Cardiol 1991, 14(2):165-8. Epub 1991/02/01
• [28]Kayal AK, Goswami M, Das M, Jain R: Clinical and biochemical spectrum of hypokalemic paralysis in North: East India. Ann Indian Acad Neurol 2013, 16(2):211-7. Epub 2013/08/21
• [29]Lumpaopong A, Kaewplang P, Watanaveeradej V, Thirakhupt P, Chamnanvanakij S, Srisuwan K, et al.: Electrolyte disturbances and abnormal urine analysis in children with dengue infection. Southeast Asian J Trop Med Public Health 2010, 41(1):72-6. Epub 2010/06/29
• [30]Granier M, Massin F, Pasquie JL: Pro- and anti-arrhythmic effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents Med Chem 2013, 12(1):83-93. Epub 2013/01/05
• [31]Feenstra J, Heerdink ER, Grobbee DE, Stricker BH: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002, 162(3):265-70. Epub 2002/02/28